ARIAаллергический ринитбронхиальная астма1.Canonica G.W., Bousquet J., Mullol J. et al. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007, v. 62, Suppl 85, p. 17-25.2.Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy. 2007, v. 62, Suppl 85, p. 9-16.3.Walker S., Khan-Wasti S., Fletcher M. et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study.J. Allergy Clin. Immunol. 2007, Aug., v. 120 (2), p. 381-387.4.Maurer M., Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy. 2007, Sep., v. 62 (9), p. 1057-1056.5.Bousquet J., Dahl R., Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007, Mar., v. 62 (3), p. 216-223.6.Bousquet J., Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. ISBN 978 92 4 156346 8. 2007, 148 pages.7.Asher M.I., Montefort S., Bjorksten B. et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006 Aug. 26, v. 368 (9537), p. 733-743.8.Ait-Khaled N., Odhiambo J., Pearce N. et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy. 2007 Mar., v. 62 (3), p. 247-258.9.Pekkarinen P.T., von Hertzen L., Laatikainen T. et al. A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia. Allergy. 2007 Mar., v. 62 (3), p. 281-287.10.Majkowska-Wojciechowska B., Pelka J., Korzon L. et al. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy. 2007 Sep; v. 62 (9), p. 1044-1050.11.Viinanen A., Munhbayarlah S., Zevgee T. et al. The protective effect of rural living against atopy in Mongolia. Allergy. 2007 Mar; v. 62 (3), p. 272-280.12.Ильина Н.И. Эпидемиология аллергического ринита. Росс. Ринология. 1999, №1, с. 23-24.13.Гущин И.С., Ильина Н.И., Польнер С.А. Аллергический ринит (пособие для врачей), М., 2002, с. 1-3.14.Лопатин А.С. Клинические рекомендации по диагностике и лечению аллергического ринита: пособие для врачей. Санкт-Петербург: ООО «РИА-АМИ». 2004, с. 48.15.Astafieva N., Maron V. Allergic diseases in Saratov Oblast, Russia ACI International, 2000, Suppl. 2, p. 101-102 (Abstract N 355, XVII Int. Congress of Allergology and Clinical Immunology, Sydney, Australia).16.Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 2001, v. 108 (5 Suppl), p. 147-334.17.Shekelle P.G., Woolf S.H., Eccles M., Grimshaw J. Clinical guidelines: developing guidelines. Bmj. 1999, v. 318 (7183), p. 593-596.18.Custovic A., Wijk R.G. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy. 2005 Sep., v. 60 (9), p. 1112-1115.19.Passalacqua G., Bousquet P.J., Carlsen K.H. et al. ARIA update: I-Systematic review of complementary and alternative medicine for rhinitis and asthma. J. Allergy Clin. Immunol. 2006 May; v. 117 (5), p. 1054-1062.20.Bonini S., Bonini M., Bousquet J. et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy. 2006 Jun., v. 61 (6), p. 681-692.21.Bousquet J., van Cauwenberge P., Ait Khaled N. et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy. 2006 Sep; v. 61 (9), p. 1086-1096.22.Passalacqua G., Durham S.R. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J. Allergy Clin. Immunol. 2007 Apr., v. 119 (4), p. 881-891.23.Cruz A.A., Popov T., Pawankar R. et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007, v. 62, Suppl 84, p. 1-41.24.Bauchau V., Durham S.R. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur. Respir J. 2004 Nov; v. 24 (5), p. 758-764.25.Demoly P., Allaert F.A., Lecasble M., Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy. 2003 Jul., v. 58 (7), p. 672-675.26.Bachert C., van Cauwenberge P., Olbrecht J., van SchoorJ. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006 Jun., v. 61 (6), p. 693-698.27.Todo-Bom A., Loureiro C., Almeida M.M. et al. Epidemiology of rhinitis in Portugal: evaluation of the intermittent and the persistent types. Allergy. 2007 Sep., v. 62 (9), p. 1038-1043.28.Van Hoecke H., Vastesaeger N., Dewulf L. et al. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J. Allergy Clin. Immunol. 2006 Sep., v. 118 (3), p. 758-759.29.Valero A., Ferrer M., Sastre J. et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J. Allergy Clin. Immunol. 2007 Aug., v. 120 (2), p. 359-365.30.Burgess J.A., Walters E.H., Byrnes G.B. et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J. Allergy Clin. Immunol. 2007 Oct., v. 120 (4), p. 863-869.31.Chatkin M.N., Menezes A.M., Victora C.G., Barros F.C. High prevalence of asthma in preschool children in Southern Brazil: a population-based study. Pediat pulmonol. 2003 Apr., v. 35 (4), p. 296-301.32.Giovannini M., Agostoni C., Riva E. et al. A Randomized Prospective Double Blind Controlled Trial on Effects of Long-Term Consumption of Fermented Milk Containing Lactobacillus casei in Pre-School Children With Allergic Asthma and/or Rhinitis. Pediatr Res. 2007 Jun 25.33.Bousquet J., Khaltaev N., Cruz A. et al. ARIA Update. Allergy. 2008, 63 (suppl.).34.Schunemann H.J., Hill S.R., Kakad M. et al. Transparent development of the WHO rapid advice guidelines. PLoS Med. 2007 May, v. 4 (5), p.119.35.Brozek J.L., Baena-Cagnani C.E., Bonini S. et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008 Jan., v. 63 (1), p. 38-46.36.Kaiser H.B., Naclerio R.M., Given J. et al. Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis. J. Allergy Clin. Immunol. 2007 Apr 4.37.Fokkens W.J., Jogi R., Reinartz S. et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007 Sep., v. 62 (9). p. 1078-84.38.Devillier P., Bousquet J. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy? Clin. Exp. Allergy. 2007 Mar., v. 37 (3), p. 400-414.39.Bachert C., Bousquet J., Canonica G.W. et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J. Allergy Clin. Immunol. 2004 Oct., v. 114 (4), p. 838-844.40.Canonica G.W., Bousquet J., Van Hammee G. et al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med. 2006 May 22.41.Virchow J.C., Bachert C. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir Med. 2006 Apr 12.42.Philip G., Nayak A.S., Berger W.E. et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr. Med. Res. Opin. 2004 Oct., v. 20 (10), p. 1549-1558.43.Barnes M.L., Menzies D., Fardon T.C. et al. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy. 2007 Jan., v. 62 (1), p. 73-80.44.Durham S.R., Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy. 2007 Aug., v. 62 (8), p. 954-957.45.Durham S.R., Yang W.H., Pedersen M.R. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 2006 Apr., v. 117 (4), p. 802-809.46.Dahl R., Kapp A., Colombo G. et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 2006 Aug., v. 118 (2), p. 434-40.47.Didier A., Malling H.J., Worm M. et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J. Allergy Clin. Immunol. 2007 Dec., v. 120 (6), p. 1338-1345.48.Canonica G.W., Baena-Cagnani C.E., Bousquet J. et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy. 2007 Mar., v. 62 (3), p. 317-324.49.Casale T.B., Romero F.A., Spierings E.L. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J. Allergy Clin. Immunol., 2007 Oct., p. 26.50.Molgaard E., Thomsen S.F., Lund T. et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy. 2007 Jun., p. 18.51.Greiner A.N., Meltzer E.O. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J. Allergy Clin. Immunol. 2006 Nov., v. 118 (5), p. 985-998.52.Linneberg A., Jorgensen T., Nielsen N.H. et al. The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy. 2000 Aug., v. 55 (8), p. 767-772.53.Terreehorst I., Oosting A.J., Tempels-Pavlica Z. et al. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin. Exp. Allergy. 2002 Aug.,v. 32 (8), p. 1160-1165.54.Georgy V., Fahim H.I., El Gaafary M., Walters S. Prevalence and socioeconomic associations of asthma and allergic rhinitis in Cairo, Egypt. Eur. Respir. J. 2006 May, 31.55.Kuyucu S., Saraclar Y., Tuncer A. et al. Epidemiologic characteristics of rhinitis in Turkish children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol. 2006 Jun., v. 17 (4)., p. 269-277.56.Antonicelli L., Micucci C., Voltolini S. et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin. Exp. Allergy. 2007 Jun., v. 37 (6), p. 954-960.57.Antonicelli L., Micucci C., Voltolini S. et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy. 2007 Sep., v. 62 (9), p. 1064-1070.58.Stelmach R., do Patrocinio T.N.M., Ribeiro M., Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest. 2005 Nov., v. 128 (5), p. 3140-3147.59.Camargos P., Ibiapina C., Lasmar L., Cruz A.A. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy. 2007 Mar., v. 62 (3), p. 310-316.60.Jacobsen L., Niggemann B., Dreborg S. et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007 Aug., v. 62 (8), p. 943-948.61.Civelek E., Soyer O.U., Gemicioglu B., Sekerel B.E. Turkish physicians' perception of allergic rhinitis and its impact on asthma. Allergy. 2006 Dec., v. 61 (12), p. 1454-1458.62.Demoly P., Concas V., Urbinelli R., Allaert F. Evaluation de l'influence des recommandations OMS-ARIA sur la prise en charge de la rhinite allergique en pratique de ville en France. Enguete ERNANI. Rev. fr Allergol. Immunol. Clin. 2006, v. 46, p. 626-632.